Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fourteen research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and two have assigned a strong buy recommendation to the […]
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fourteen research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and two have assigned a strong buy recommendation to the […]
